BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasprzak A, Adamek A. The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management. Int J Mol Sci 2020;21:E3494. [PMID: 32429087 DOI: 10.3390/ijms21103494] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Qiu P, Chen X, Xiao C, Zhang M, Wang H, Wang C, Li D, Liu J, Chen Y, Liu L, Zhao Q. Emerging glyco-risk prediction model to forecast response to immune checkpoint inhibitors in colorectal cancer. J Cancer Res Clin Oncol 2023. [PMID: 36757621 DOI: 10.1007/s00432-023-04626-0] [Reference Citation Analysis]
2 Ayala G. Neuroepithelial Interactions in Cancer. Annu Rev Pathol 2023;18:493-514. [PMID: 36323005 DOI: 10.1146/annurev-pathmechdis-031521-023248] [Reference Citation Analysis]
3 Zhang Y, Lin C, Liu Z, Sun Y, Chen M, Guo Y, Liu W, Zhang C, Chen W, Sun J, Xia R, Hu Y, Yang X, Li J, Zhang Z, Cao W, Sun S, Wang X, Ji T. Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies. Cell Metab 2022;34:1999-2017.e10. [PMID: 36395769 DOI: 10.1016/j.cmet.2022.10.012] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Jaén M, Martín-Regalado Á, Bartolomé RA, Robles J, Casal JI. Interleukin 13 receptor alpha 2 (IL13Rα2): Expression, signaling pathways and therapeutic applications in cancer. Biochim Biophys Acta Rev Cancer 2022;1877:188802. [PMID: 36152905 DOI: 10.1016/j.bbcan.2022.188802] [Reference Citation Analysis]
5 Srivastava A, Rikhari D, Pradhan B, Bharadwaj KK, Gaballo A, Quarta A, Jena M, Srivastava S, Ragusa A. An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives. Applied Sciences 2022;12:8990. [DOI: 10.3390/app12188990] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Li S, Chen J, Chen X, Yu J, Guo Y, Li M, Pu X. Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape. Front Pharmacol 2022;13:997664. [DOI: 10.3389/fphar.2022.997664] [Reference Citation Analysis]
7 Sánchez ML, Coveñas R. The Galaninergic System: A Target for Cancer Treatment. Cancers 2022;14:3755. [DOI: 10.3390/cancers14153755] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Li L, Xiao F, Liu G, Chen Y, Xu Y. Serum Exosomal lncRNA AC007099.1 Regulates the Expression of Neuropeptide-Related FAP, as a Potential Biomarker for Hepatocarcinogenesis. Disease Markers 2022;2022:1-13. [DOI: 10.1155/2022/9501008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kasprzak A. Somatostatin and Its Receptor System in Colorectal Cancer. Biomedicines 2021;9:1743. [PMID: 34829972 DOI: 10.3390/biomedicines9111743] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Liu J, Zhang Y, Li Q, Wang Y. Transgelins: Cytoskeletal Associated Proteins Implicated in the Metastasis of Colorectal Cancer. Front Cell Dev Biol 2020;8:573859. [PMID: 33117801 DOI: 10.3389/fcell.2020.573859] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]